|NTLA||INTELLIA THERAPEUTICS INC||3.41%|
|XLRN||ACCELERON PHARMA INC||2.20%|
|CTLT||CATALENT INC USD 0.01||2.07%|
|NRIX||NURIX THERAPEUTICS INC||2.05%|
|EW||EDWARDS LIFESCIENCES CORP||2.04%|
|ARVN||ARVINAS INC USD||2.01%|
|ASND||ASCENDIS PHARMA A/S DKK 1.0 ADR||1.91%|
|STAA||STAAR SURGICAL CO||1.90%|
|CRL||CHARLES RIVER LABORATORIES INT INC||1.88%|
|BGNE||BEIGENE LTD USD 0.0001 ADR||1.87%|
|BCRX||BIOCRYST PHARMACEUTICALS INC||1.86%|
|TWST||TWIST BIOSCIENCE CORP USD 0.00001||1.85%|
|HZNP||HORIZON THERAPEUTICS PLC||1.85%|
|SRPT||SAREPTA THERAPEUTICS INC||1.84%|
|HCA||HCA HOLDINGS INC||1.84%|
|SRRK||SCHOLAR ROCK HLDG CORP USD||1.80%|
|LLY||ELI LILLY CORP||1.76%|
|MOH||MOLINA HEALTHCARE INC||1.72%|
|CRSP||CRISPR THERAPEUTICS AG||1.70%|
|GH||GUARDANT HEALTH INC||1.68%|
|IMAB||I-MAB CNY 0.0001 ADR||1.65%|
|TPTX||TURNING PT THERAPEUTICS||1.64%|
|TXG||10X GENOMICS INC||1.61%|
|LH||LABORATORY CORP OF AMERICA||1.60%|
|TGTX||TG THERAPEUTICS INC||1.55%|
|ITCI||INTRA-CELLULAR THERAPIES USD||1.55%|
|ARNA||ARENA PHARMACEUTICALS INC||1.55%|
|EXAS||EXACT SCIENCES CORP||1.49%|
|SWTX||SPRINGWORKS THERAPEUTICS USD||1.48%|
|BBIO||BRIDGEBIO PHARMA INC||1.45%|
|BMY||BRISTOL MYERS SQUIBB CO||1.41%|
|XRAY||DENTSPLY SIRONA INC||1.40%|
|FATE||FATE THERAPEUTICS INC||1.30%|
|RCKT||ROCKET PHARMACEUTICALS INC USD||1.24%|
|RARE||ULTRAGENYX PHARMACEUTICAL INC||1.24%|
|GTHX||G1 THERAPEUTICS INC||1.13%|
|ZLAB||ZAI LAB LTD||1.13%|
|TCRR||TCR2 THERAPEUTICS INC||0.72%|
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2021 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.